Concepedia

Safety Database Review

Safety Database Review is a systematic evaluation process, as an academic concept, that belongs to the class of pharmacovigilance methodologies, distinguished by its structured analysis of accumulated safety data from clinical trials and real-world sources to identify, assess, and interpret potential adverse drug reactions over time within a predefined population.

108

Publications

6.1K

Citations

622

Authors

291

Institutions

Publications per year

2017–2026

40

Parents

Publications

108

Validity of the General Practice Research Database

Susan S. Jick, James A. Kaye, Catherine Vasilakis‐Scaramozza et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2003 · 586 citations · Full text

, , +13

The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions

Karin Fattinger · Clinical Pharmacology & Therapeutics · 2001 · 505 citations · Full text

, , +17

Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid Arthritis

Jeffry Katz, Christian Antoni, Gregory F. Keenan et al. · The American Journal of Gastroenterology · 2004 · 467 citations

, , +17

Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events

G. Niklas Norén, Andrew Bate, Roland Orre et al. · Statistics in Medicine · 2005 · 197 citations

, , +16

MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database

Michele Pellegrini, Uwe Nicolay, Kelly Lindert et al. · Vaccine · 2009 · 184 citations

, , +14

1–5 of 108

Authors

622

  1. ME
    Megan E. B. Clowse

    Duke Medical Center, United States

    4 publications · 311 citations

    4

    h-index

  2. AB
    Alexa B. Kimball

    Harvard University, United States

    3 publications · 237 citations

    3

    h-index

  3. WL
    Walter L. Straus

    United States Military Academy, United States

    3 publications · 60 citations

    3

    h-index

  4. UM
    Uma Mahadevan

    University of California, San Francisco, United States

    3 publications · 147 citations

    3

    h-index

  5. BH
    Bernhard Hemmer

    Technical University of Munich, Germany

    2 publications · 173 citations

    2

    h-index

1–5 of 622

Institutions

291

  1. University of California, San Francisco

    San Francisco, United States

    5 h-index

    24 publications

    1.6K citations

  2. Harvard University

    Cambridge, United States

    5 h-index

    10 publications

    445 citations

  3. Duke Medical Center

    Durham, United States

    5 h-index

    5 publications

    355 citations

  4. National Patient Safety Foundation

    Boston, United States

    5 h-index

    15 publications

    784 citations

  5. Pfizer (United States)

    New York, United States

    4 h-index

    25 publications

    791 citations

  6. University of California San Diego

    San Diego, United States

    4 h-index

    7 publications

    793 citations

  7. Janssen (United States)

    Hopewell, United States

    4 h-index

    17 publications

    386 citations

  8. Inserm

    Paris, France

    3 h-index

    12 publications

    365 citations

1–8 of 291

Venues

  1. Drug Safety

    5 publications · 154 citations

    5

    h-index

  2. Clinical Pharmacology & Therapeutics

    CPT · 3 publications · 575 citations

    3

    h-index

  3. Pharmacoepidemiology and Drug Safety

    2 publications · 56 citations

    2

    h-index

  4. Nucleic Acid Therapeutics

    2 publications · 152 citations

    2

    h-index

  5. Frontiers in Pharmacology

    2 publications · 38 citations

    2

    h-index

1–5